rhG-CSF is associated with an increased risk of metastasis in NSCLC patients following postoperative chemotherapy. Wang Y, Fang C, Chen R, Yuan S, et al. BMC Cancer 2022;22:741.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang Y, Fang C, Chen R, Yuan S, et al. rhG-CSF is associated with an increased risk of metastasis in NSCLC patients following postoperative chemotherapy. BMC Cancer 2022;22:741.
PMID: 35799161